Vaspin (human) ELISA Kit (Twin Plex)

Serum vaspin concentrations in human obesity and type 2 diabetes: B.S. Youn, et al.; Diabetes 57, 372 (2008) | Serum levels of the adipokine vaspin in relation to metabolic and renal parameters: J. Seeger, et al.; J. Clin. Endocrinol. Metab. 93, 247 (2008) | Metformin decreases the Adipokine Vaspin in overweight women with the polycystic ovary syndrome: Concomitant improvement in insulin sensitivity and a decrease in insulin resistance: B.K. Tan, et al.; Diabetes 57, 1501 (2008) | Vaspin: a novel serpin with insulin-sensitizing effects: J. Wada; Expert Opin. Investig. Drugs 17, 327 (2008) | Vaspin serum concentrations in patients with carotid stenosis: G. Aust, et al.; Atherosclerosis 204, 262 (2009) | Serum vaspin levels in type 2 diabetic women in relation to microvascular complications: N.E. Gulcelik, et al.; Eur. J. Endocrinol. 160, 65 (2009) | Serum Visceral Adipose Tissue?Derived Serine Protease Inhibitor Concentrations in Human Obesity and Polycystic Ovary Syndrome: H.F. Escobar-Morreale, et al.; Diabetes Care 32, e6 (2009) | Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months: L. Ibanez, et al.; Clin. Endocrinol. (Oxf) 71, 351 (2009) | Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia: H. Stepan, et al.; Metabolism 59, 1054 (2010) | Circadian Rhythm of Serum Vaspin in Healthy Male Volunteers: Relation to Meals: E. Jeong, et al.; J. Clin. Endocrinol. Metab. 95, 1869 (2010) | Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss: A. Handisurya, et al.; Obes. Surg. 20, 198 (2010) | Serum chemerin and vaspin in non-alcoholic fatty liver disease: M. Kukla, et al.; Scand. J. Gastroenterol. 45, 235 (2010) | Chemerin, vaspin and insulin resistance in chronic hepatitis C: M. Kukla, et al.; J. Viral Hepat. 17, 661 (2010) | Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men: J.K. Chou, et al.; Eur. J. Appl.Physiol. 108, 347 (2010) | Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects: H.M. Chang, et al.; Metabolism 59, 1276 (2010) | Reduced serum vaspin concentrations in obese children following shortterm intensive lifestyle modification: M.K. Lee, et al.; Clin. Chim. Acta 411, 381 (2010) | Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance: H.M. Chang, et al.; Obesity (Silver Spring) 18, 2105 (2010) | Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans: C. von Loeffelholz, et al.; Eur. J. Endocrinol. 162, 507 (2010) | Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis: L. Senolt, et al.; Ann. Rheum. Dis. 69, 1410 (2010) | Comparison of orlistat treatment and placebo in obese type 2 diabetic patients: G. Derosa, et al.; Expert. Opin. Pharmacother. 11, 1971 (2010) | Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients: G. Derosa, et al.; Fundam. Clin. Pharmacol. 25, 642 (2011) | Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus: H.O. El-Mesallamy, et al.; Metabolism 60, 63 (2011) | Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients: G. Derosa, et al.; Metabolism 60, 421 (2011) | Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism: G.A. Martos-Moreno, et al.; Int. J. Obes. (Lond) 35, 1355 (2011) | Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies: D.D. Briana, et al.; Metabolism 60, 486 (2011) | Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children: A. K?rner, et al.; Int. J. Obes. (Lond) 35, 578 (2011) | Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients: G. Derosa, et al.; Hypertens. Res. 34, 145 (2011) | Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations: S.M. Kim, et al.; Metabolism 60, 1294 (2011) | Adipokine profile is modulated in subcutaneous adipose tissue by TNF{alpha} inhibitors in patients with rheumatoid arthritis: L. Senolt, et al.; Ann. Rheum. Dis. 70, 2054 (2011) | New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women: T. Auguet, et al.; BMC Med. Genet. 12, 60 (2011) | Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome: E. Cakal, et al.; Gynecol. Endocrinol. 27, 491 (2011) | Serum vaspin levels in hypothyroid patients: N. Cinar, et al.; Eur. J. Endocrinol. 165, 563 (2011) | Correlation of Circulating Omentin-1 with Bone Mineral Density in Multiple Sclerosis: The Crosstalk between Bone and Adipose Tissue: M. Assadi, et al.; PLoS One 6, e24240 (2011) | Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris: H.L. Li, et al.; Clin. Chem. Lab. Med. 49, 1547 (2011) | Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects: A. Golpaie, et al.; Eur. Cytokine Netw. 22, 181 (2011) | Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients: M. Kukla, et al.; Pol. J. Pathol. 62, 218 (2011) | Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease: A. Fioravanti, et al.; Rheumatol. Int. 32, 1481 (2012) | Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention: M. Bl?her, et al.; Diabetes Care 35, 342 (2012) | Increased levels and adipose tissue expression of visfatin in morbidly obese women. The relationship with pro-inflammatory cytokines: X. Terra, et al.; Clin. Endocrinol. (Oxf.) 77, 691 (2011) | Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis: R. Klaasen, et al.; Ann. Rheum. Dis. 71, 1510 (2012) | The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome: K. Schindler, et al.; Obes. Facts 5, 270 (2012) | Vaspin-a link of obesity and psoriasis?: A. Saalbach, et al.; Exp. Dermatol. 21, 309 (2012) | Post-Resistance Exercise Response of Vaspin Adipocytokin and its Relation to Insulin and Glucose Levels in Overweight Women: M. Ghahramani, et al.; Middle-East J. Sci. Res. 11, 1328 (2012) | Genetic variation in the vaspin gene affects circulating serum vaspin concentrations: J. Breitfeld, et al.; Int. J. Obes. 37, 861 (2013) | Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study: H.L. Li, et al.; Clin. Chim. Acta. 415, 233 (2013) | Vaspin concentration in obesity, impaired glucose tolerance and Type 2 diabetes in Egypt: H.B. Atya, et al.; Adv. Res. Biol. Sci. 1, 6 (2013) | Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects: Z. Goktas, et al.; Mediators Inflamm. 2013, 861496 (2013) | Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation: G. Flehmig, et al.; PLoS One 9, e99785 (2014) | Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis: J.-P. Bao, et al.; Int. J. Clin. Exp. Med. 7, 3447 (2014) | Association of vaspin with metabolic syndrome: The pivotal role of insulin resistance: A. Esteghmatai, et al.; Diabet. Metab. 38, 143 (2014) | Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome: Y. Guvenc, et al.; J. Int. Med. Res. 44, 796 (2016)